Type6 Therapeutics
Biotechnology company developing a new class of bifunctional kinase inhibitors to target historically hard-to-drug cancers using rational engineering to create highly specific, high avidity molecules.
Location
Boston, Massachusetts, USA
Founded
2021
Investors
1
Categories
oncology, therapeutics, kinase-inhibitors, biotech, drug-discovery
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |